Cargando…
Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
Fulminant myocarditis (FM) is the severest type of myocarditis and requires timely diagnosis and treatment. However, effective biomarkers for early diagnosis of FM are limited. First, 12 common inflammatory cytokines levels in the plasma of patients with FM were measured using human cytokine 12-Plex...
Autores principales: | Zhuang, Yan, Wang, Jin, Li, Huihui, Chen, Yanghui, Chen, Chen, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687192/ https://www.ncbi.nlm.nih.gov/pubmed/36428509 http://dx.doi.org/10.3390/biomedicines10112941 |
Ejemplares similares
-
Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
por: Wang, Jin, et al.
Publicado: (2022) -
SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020) -
Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
por: Xie, Jiexiong, et al.
Publicado: (2018) -
Self-recruited neutrophils trigger over-activated innate immune response and phenotypic change of cardiomyocytes in fulminant viral myocarditis
por: Li, Huihui, et al.
Publicado: (2023) -
Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)